TIS21 /BTG2/PC3 as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule

Abstract

TIS21/BTG2/PC3 , orthologs of mouse, human and rat, respectively, is initially identified as one of the early growth response genes and induced by various stimulations. TIS21 belongs to antiproliferative (APRO) gene family containing the BTG-Box A (Y 50 -N 71 ) and BTG-Box B (L 97 -E 115 ), which are highly conserved among various species. On the other hand, it has lately been found that the expression of TIS21 is constitutive and high in thymus, lung alveolar epithelium, proximal tubule of kidney and basal cell layer of prostate acini. Potential roles of TIS21 have been suggested as transcriptional co-regulator, differentiation and antiapoptotic factor in neurogenesis, key mediator of the stagespecific expansion of thymocyte and negative regulator of hematopoietic progenitor expansion, and tumor suppressor gene in both mouse and human. In addition, as pan-cell cycle regulator TIS21 induces G1/S arrest by pRB dependently and pRB independently and G2/M arrest and cell death in the p53 null tumor cells, and regulates the development of vertebrate patterning in mouse, paraxial mesoderm development in zebrafish, and notochord development in Xenopus. It has been known that the expression of TIS21 depends on the induction of wt p53 when cells are damaged, however, it can also be upregulated p53 independently by the activation of PKC-d pathway in tumor cells. The characteristic roles of TIS21 are discussed in the present review: (1) TIS21 inhibits early phase of carcinogenesis in its high expressers such as kidney, prostate, breast and thymus: Loss of constitutive and high expression of TIS21 was observed in the precancerous lesions as well as tumor tissues. As an endogenous cell death molecule, TIS21 may be involved in translocation of Pin-1 to cytoplasm. Pin-1 subsequently interacts with Serine 147 residue in TIS21 protein, resulting in mitochondrial depolarization. (2) TIS21 regulates transition of cell cycle at G1/S and G2/M phases in cancer cells with inactive pRB and/or p53, as well as in normal cells by regulating pRB/p16INK4a pathway. The latter has already been well elucidated; TIS21 inhibits the expression of cyclin D1, thus resulting in the arrest of cells at G1/S phase by pRB and p53 dependent manner. On the other hand, TIS21 inhibits degradations of cyclin A and cyclin B1 at G2/M phase, and directly binds to Cdc2, resulting in the failure of mitotic exit and then increasing the tumor cell death, when stimulated by high concentration of EGF. Therefore, TIS21 can be suggested as a pan-cell cycle modulator. (3) TIS21 regulates embryo development by activating BMP signal through interaction with Smad 1 and Smad 8, thereby regulating vertebral patterning in mice. It is also involved in notochord development in Xenopus and paraxial mesoderm development in zebrafish. Based on the previous report that the expression of TIS21 is involved in the induction of senescence after chemotherapy of cancer cells, which can be a mechanism to resist carcinogenesis, TIS21 /BTG2/ PC3 , the endogenous cell death mol...

Ebf1orPax5haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia

“…These include several potential tumor suppressor genes including Bcl7a, Cyfip2, and Rgs2 (Zani et al, 1996;Jackson et al, 2007;Schwäble et al, 2005;van Doorn et al, 2005). Likewise, 25% of PAX5-induced genes were also downregulated in Stat5b-CA x Ebf1 +/ leukemias, including potential tumor suppressor genes or genes involved in suppressing cell proliferation such as Bach2, Btg1, Btg2, and Ucp2 (Table S3; Rouault et al, 1992Rouault et al, , 1996Sasaki et al, 2000;Lim, 2006;Baffy, 2010). Interestingly, in the case of PAX5- .…”

B-Cell Translocation Gene 2 Regulates Hepatic Glucose Homeostasis via Induction of Orphan Nuclear Receptor Nur77 in Diabetic Mouse Model

“…Expression vectors of HA-Nur77, dominant-negative (DN)-Nur77, Hnf4-a, Pgc-1a, GR, and Flag-Btg2 were described previously (13,18,(20)(21)(22)(23). The small interfering RNAs for Btg2 were prepared as described previously (18).…”

Btg1 and Btg2 gene expression during early chick development

“…It has been suggested that Btg proteins exert cellular functions by interacting with transcriptional coactivators or corepressors, hence modulating their transcriptional activities (Matsuda et al, 2001;Tirone, 2001;Duriez et al, 2004;Lim, 2006). For example, it has been found that Btg2 impairs G1-S cell cyclephase progression by inhibiting cyclin D1 transcription (Guardavaccaro et al, 2000), that it can associate with HoxB9 (Prevot et al, 2000), and BMPregulated Smad1 and 8 (Park et al, 2004) to promote their transcriptional activity, and that it can enhance Math1 promoter activity (Canzoniere et al, 2004).…”

“…Btg/ Tob genes are a newly characterized family of cell cycle modulators (Guehenneux et al, 1997). Studies in different model systems suggest that they act as antiproliferative genes, they can promote cell differentiation and also regulate apoptosis and cellular senescence (Matsuda et al, 2001;Tirone, 2001;Duriez et al, 2004;Lim, 2006). Btg/Tob genes encode for a group of structurally related proteins, characterized by the presence of two novel and highly conserved domains ("antiproliferative" boxes A and B) located in the first 120 residues of the protein (Guehenneux et al, 1997;Guardavaccaro et al, 2000).…”